GEn1E Lifesciences
$11.5M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
GEn1E Lifesciences is currently valued at $141.0M as of October 21, 2025. The company has raised a total of $31.5M in funding.
Capital Efficiency
With a capital efficiency ratio of 4.47x, GEn1E Lifesciences has achieved a valuation that is 4.47 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
GEn1E Lifesciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is GEn1E Lifesciences Worth in 2025?
As of 2025, GEn1E Lifesciences is valued at $141.0M, based on the company's Seed Round funding round in October 21, 2025. This valuation positions GEn1E Lifesciences as one of the leading private companies in the sector.
GEn1E Lifesciences Valuation History
GEn1E Lifesciences's funding history demonstrates steady growth and investor confidence.
How GEn1E Lifesciences Valuation is Determined
Private company valuations like GEn1E Lifesciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
GEn1E Lifesciences Valuation FAQs
Is GEn1E Lifesciences profitable?
GEn1E Lifesciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does GEn1E Lifesciences's valuation compare to competitors?
GEn1E Lifesciences is valued at $141.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will GEn1E Lifesciences IPO?
GEn1E Lifesciences has not announced plans for an initial public offering. Until an IPO, investors can access GEn1E Lifesciences shares through secondary market platforms.